Skip to main content

Not investment advice.Read full disclaimer

Healthcare Stocks | finqOS Stock Screener | finqOS

Healthcare stocks

Stocks sorted by market cap.

All Basic Materials Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Healthcare Industrials Real Estate Technology Utilities

RHH

Roche Holding AG

RHHBY · $332.6B

SanofiSNY · $114.3B

Regeneron Pharmaceuticals, Inc.REGN · $76.6B

ResMed Inc.RMD · $37.7B

Revolution Medicines, Inc.RVMD · $18.7B

Royalty Pharma plcRPRX · $18.1B

Roivant Sciences Ltd.ROIV · $15.0B

Smith & Nephew plcSNN · $14.9B

Solventum CorporationSOLV · $13.4B

Revvity, Inc.RVTY · $12.6B

Regencell Bioscience Holdings LimitedRGC · $12.4B

Dr. Reddy's Laboratories LimitedRDY · $11.2B

Qiagen N.V.QGEN · $11.1B

Atrium Therapeutics, Inc.RNA · $10.9B

Summit Therapeutics Inc.SMMT · $10.8B

Repligen CorporationRGEN · $8.4B

Rhythm Pharmaceuticals, Inc.RYTM · $6.8B

PTC Therapeutics, Inc.PTCT · $6.1B

RadNet, Inc.RDNT · $5.4B

Sotera Health CompanySHC · $5.1B

Protagonist Therapeutics, Inc.PTGX · $5.1B

Scholar Rock Holding CorporationSRRK · $4.5B

Sugi Holdings Co.,Ltd.SGIPF · $2.9B

Privia Health Group, Inc.PRVA · $2.9B

Ultragenyx Pharmaceutical Inc.RARE · $2.3B

Sarepta Therapeutics, Inc.SRPT · $2.1B

Arcus Biosciences, Inc.RCUS · $2.1B

Soleno Therapeutics, Inc.SLNO · $2.1B

Perrigo Company plcPRGO · $2.0B

Surgery Partners, Inc.SGRY · $1.9B

Sionna Therapeutics, Inc.SION · $1.9B

Select Medical Holdings CorporationSEM · $1.9B

QuidelOrtho CorporationQDEL · $1.8B

Syndax Pharmaceuticals, Inc.SNDX · $1.8B

Recursion Pharmaceuticals, Inc.RXRX · $1.7B

PROCEPT BioRobotics CorporationPRCT · $1.6B

uniQure N.V.QURE · $1.4B

Relay Therapeutics, Inc.RLAY · $1.3B

Sana Biotechnology, Inc.SANA · $1.2B

Septerna, Inc.SEPN · $1.0B

Schrödinger, Inc.SDGR · $1.0B

ARS Pharmaceuticals, Inc.SPRY · $987M

Rapport Therapeutics, Inc. Common StockRAPP · $971M

RAPT Therapeutics, Inc.RAPT · $954M

Palvella Therapeutics, Inc.PVLA · $908M

Personalis, Inc.PSNL · $832M

SI-BONE, Inc.SIBN · $719M

Prime Medicine, Inc.PRME · $688M

Rigel Pharmaceuticals, Inc.RIGL · $633M

Surmodics, Inc.SRDX · $615M

Sonida Senior Living, Inc.SNDA · $598M

REGENXBIO Inc.RGNX · $565M

ProKidney Corp.PROK · $557M

Replimune Group, Inc.REPL · $551M

Solid Biosciences Inc.SLDB · $503M

SIGA Technologies, Inc.SIGA · $480M

Prothena Corporation plcPRTA · $474M

PureTech Health plcPRTC · $452M

SELLAS Life Sciences Group, Inc.SLS · $426M

SNDL Inc.SNDL · $397M

Palatin Technologies, Inc.PTN · $383M

Rocket Pharmaceuticals, Inc.RCKT · $377M

RxSight, Inc.RXST · $357M

SOPHiA GENETICS S.A.SOPH · $356M

Simulations Plus, Inc.SLP · $340M

Sight Sciences, Inc.SGHT · $332M

Semler Scientific, Inc.SMLR · $311M

Rezolute, Inc.RZLT · $310M

Senseonics Holdings, Inc.SENS · $299M

Quanterix CorporationQTRX · $296M

Shoulder Innovations, Inc.SI · $292M

Spok Holdings, Inc.SPOK · $284M

Relmada Therapeutics, Inc.RLMD · $260M

Prenetics Global LimitedPRE · $253M

Reviva Pharmaceuticals Holdings, Inc.RVPH · $244M

SANUWAVE Health, Inc.SNWV · $231M

Silence Therapeutics plcSLN · $228M

Profound Medical Corp.PROF · $227M

Quantum-Si incorporatedQSI · $221M

Sanara MedTech Inc.SMTI · $197M

Rapid Micro Biosystems, Inc.RPID · $196M

Sangamo Therapeutics, Inc.SGMO · $180M

Sol-Gel Technologies Ltd.SLGL · $179M

Cartesian Therapeutics, Inc.RNAC · $178M

Sagimet Biosciences Inc.SGMT · $176M

ProQR Therapeutics N.V.PRQR · $171M

Quipt Home Medical Corp.QIPT · $158M

Spero Therapeutics, Inc.SPRO · $123M

Repare Therapeutics Inc.RPTX · $114M

AVITA Medical, Inc.RCEL · $110M

Sera Prognostics, Inc.SERA · $104M

Seer, Inc.SEER · $102M

Prelude Therapeutics IncorporatedPRLD · $102M

Cassava Sciences, Inc.SAVA · $96M

Pyxis Oncology, Inc.PYXS · $90M

Rani Therapeutics Holdings, Inc.RANI · $88M

Scilex Holding CompanySCLX · $73M

Quince Therapeutics, Inc.QNCX · $6M

Quoin Pharmaceuticals, Ltd.QNRX · $3M

Silexion Therapeutics Ltd.SLXN ·

← Previous7 / 9Next →

finqOS provides healthcare stock analysis including real-time quotes, financial statements, key ratios, insider trades, institutional ownership from 13F filings, SEC filings, and earnings transcripts. 14-day free trial.